Maya's Method
The blog · @mayasmethod
There's a piece of arithmetic a lot of women are doing in private right now. It goes like this: take the monthly number, multiply by twelve, then sit with the uncomfortable question of how many years that multiplication is supposed to cover.
One community member described her decision in exactly those terms: "I tried coming off it in November 2025 because I knew I couldn't justify paying for it forever, especially with the price increases."
Paying for it forever. That's the phrase that matters, and it's the part most cost articles skip. They tell you the monthly price and stop, as if this were a three-month purchase. So let's do the whole calculation together, calmly, without scare tactics, because you deserve to see the real number before you commit to it.
As of this writing, the US list price for Ozempic sits just under $1,000 a month. That's the sticker price, and almost nobody should pay it, but plenty of people effectively do, because insurance coverage for weight loss is patchy. Many plans cover GLP-1 medications for type 2 diabetes but exclude them for weight management entirely, and some employers have been dropping that coverage rather than adding it.
If you're paying out of pocket, the realistic floor is lower than list. The manufacturers now run direct self-pay programs that price semaglutide and tirzepatide roughly in the $350 to $500 a month range depending on the drug and dose. Compounded versions used to undercut that, but regulators have sharply restricted mass compounding of these medications, so that cheaper lane has mostly closed, and what remains of it sits in a gray zone I'd be careful with.
So the honest monthly range for someone without coverage is roughly $350 on the best direct-pay deal to about $1,000 at list. Call it $500 as a realistic middle.
Now the part you're already doing in your head at 11pm.
At $500 a month, a year costs about $6,000. At list price, a year runs close to $12,000. Even at the friendliest direct-pay price, you're around $4,200 a year.
And here's why the number of years matters so much. These medications manage appetite while you take them. They don't retrain what's underneath. The manufacturer's own maintenance trial (SURMOUNT-4) found that people who stopped the medication regained, on average, about two thirds of the weight they had lost within a year, while people who stayed on it kept doing well. That's not a flaw being hidden from you. It's how the medication is designed to work, the same way blood pressure medication works while you take it.
But it changes the budget question completely. If the medication does its job and you want to keep the result, the honest planning horizon isn't "until I hit my goal weight." It's indefinite. Five years at the middle price is around $30,000. Five years at list is closer to $60,000. Ten years, double it.
I want to be fair here: for some women, that money buys something nothing else has delivered, including quiet from food noise they've fought their whole lives. If the math works for your life, it can be worth every dollar, and that's a valid choice nobody should shame. The point isn't that the number is scandalous. The point is that it's the real number, and you should get to see it before you start, not discover it two years in.
There's one more variable, and it cuts both ways.
Prices on these medications have not held still. In 2025, one manufacturer sharply raised the out-of-pocket price in the UK, and the communities of people paying for it themselves felt it within weeks. That's the backdrop behind the "especially with the price increases" in the quote above. In the US, the movement has recently gone the other direction, with direct-pay programs and negotiated pricing pulling self-pay costs down from where they were a year or two ago.
Both things are true, which is exactly the problem for planning. When you commit to an open-ended monthly cost, you're also accepting that someone else sets the price and can change it. You can't budget on a promise in either direction.
I want to bring in the community voices here, because this part gets lived quietly and rarely gets written about honestly.
One person put it simply: "I had to stop for good because it just wasn't financially sustainable." Another, weighing the same trade-off: "I was paying for Zepbound out of pocket last year and that was definitely not ideal."
And when people do stop for financial reasons, the regain data stops being a statistic. The same woman who couldn't justify the cost wrote that within a month she'd gained back a noticeable amount, and that the harder part wasn't the scale, it was the appetite and constant food thoughts returning. That's the cruelest version of this cycle: not choosing to stop, but being priced out mid-journey, and then watching the result unwind through no fault of your own effort.
That risk belongs in the cost calculation too. An affordable start you can't sustain can leave you back where you began, minus the money.
If the full-price math doesn't work for you, here's the real menu, from most to least similar to what you'd be giving up.
Check your actual coverage first. Not the rumor version. Call your insurer and ask specifically about GLP-1 coverage for your situation, and ask your doctor whether any diagnosis you genuinely have changes the coverage picture. People overpay simply because nobody walked them through this.
Use the manufacturer direct programs. If you're self-paying, buying through the manufacturers' own pharmacy channels is currently the legitimate low price. If you're paying more than that out of pocket at a retail counter, you're likely overpaying.
Ask your prescriber about maintenance dosing. Some prescribers work with patients on lower maintenance doses or adjusted schedules once they've reached their goal. This is a medical decision, not a money hack, so it belongs in your doctor's office, but it's a real conversation people are having.
Watch the pill versions. Oral GLP-1 medications are arriving, and pills are generally cheaper to make than injector pens. Nobody can promise what they'll cost, but the direction of travel may help prices over the next few years.
Be careful with the bargain lane. Heavily discounted "semaglutide" from unregulated sellers is where the savings story goes wrong. With mass compounding restricted, some of what's sold cheap online is untested or mislabeled. Saving money on something you inject is not the place to gamble.
And then there's the non-drug path. Which deserves its own honest section.
Let me be direct about the limits first, because this is where a lot of wellness marketing gets slippery. No tea, supplement, or habit will suppress your appetite the way a GLP-1 medication does. Nothing natural produces 15 to 20 percent body weight loss on its own, and anyone who implies otherwise is selling you a story.
Here's what the non-drug path can honestly offer: it targets a different problem, and for a lot of women it's the actual problem. If your situation is bloating, afternoon crashes, and the same ten or fifteen pounds cycling on and off after years of dieting, your body may be stuck in what we call "hold mode," its protective response to years of restrictive dieting, where it guards resources because every past diet taught it scarcity was coming. Drug-level appetite suppression is a blunt tool for that. What tends to help is steadier digestion, steadier energy, and daily habits your body stops reading as a threat. That's the territory The Pattern Interrupt works in, our 28-day framework built on one small daily ritual and consistency instead of restriction.
The financial profile is the opposite of the medication's. It costs little or nothing, the results are slower and smaller, and what you build is yours to keep at no monthly fee. Nobody can raise the price of a habit you already own. If you want to see how we approach it, it's all laid out at mayasmethod.com.
The fair summary: the drug path buys a powerful result with an open-ended subscription. The non-drug path builds a modest result you own outright. Some women genuinely need the first. Many are better served by the second. And some do the first while building the second, so that stopping someday isn't a cliff.
How much does Ozempic cost per month without insurance? As of this writing, the US list price is just under $1,000 a month, while manufacturer direct self-pay programs put GLP-1 medications roughly in the $350 to $500 range. Prices have moved repeatedly in both directions, so verify current numbers before you budget.
How much does Ozempic cost per year? At realistic self-pay prices, roughly $4,200 to $12,000 a year depending on where between the direct-pay floor and list price you land. The bigger question is how many years to multiply by, since maintenance is open-ended for most people who want to keep their results.
Do you have to stay on Ozempic forever? That's a conversation for your prescriber, but the manufacturer's own maintenance trial (SURMOUNT-4) showed that most people who stopped regained about two thirds of the lost weight within a year. Practically, budget as if the cost is ongoing, and treat anything shorter as good news.
Can a tea or supplement replace Ozempic to save money? No. Botanicals may support digestion, comfort, and steady energy, and habit-based approaches can genuinely change how you feel day to day, but nothing over the counter replicates prescription-level appetite suppression. If you're on a GLP-1 now, never stop it over cost without talking to your prescriber first, because there are usually cheaper legitimate options to try before quitting.
Maya's Method is a women's wellness education brand focused on female metabolism. The Pattern Interrupt is a 28-day metabolic reset framework created by Maya's Method.
The tea these guides keep mentioning is LuluTox, my custom 13-in-1 blend: matcha, sencha green tea, yerba mate, oolong, goji, ginseng, milk thistle, and dandelion, with no senna and no laxatives. My blend, my site, nowhere else.
See the blend on mayasmethod.com